A Novel Pregelatinized Starch as a Sustained-Release Matrix Excipient - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

A Novel Pregelatinized Starch as a Sustained-Release Matrix Excipient
The authors examine the use of a novel highly functional pregelatinized starch as a controlled-release matrix excipient.

Pharmaceutical Technology

Results and discussion

Preliminary screening of matrix excipients: influence of α-amylase in dissolution media. Several thermally modified starches were investigated as matrix-forming excipients for sustained-release tablets (10–14). These studies pointed out that only fully pregelatinized starches functioned for the purpose of forming matrices because of their high gelling capacities (11, 13, 14). However, it was reported that matrix tablets with fully pregelatinized starch could not provide stable drug-release profiles when α-amylase was added in test media to mimic the gastrointestinal environment (11).

The influence of α-amylase on drug release from HS matrix tablets was investigated and compared with commercially available partially and fully pregelatinized starches. Four different tablets, composed of APAP, MCC, and modified starch (HS, Starch 1500, Amycol C, and Amycol HF) were tested.

Figure 2
Figure 2 shows the dissolution profiles of APAP from various starch matrix tablets (starch/APAP/MCC = 60%/10%/30%) in different two buffers, JP-2 buffer without α-amylase (see Figure 2a) and JP-2 buffer with α-amylase in a 5-g/L concentration (see Figure 2b). The activity of α-amylase was adjusted to 1700 IU/L, which is close to the median α-amylase activity in pancreatic juice (11).

Matrix tablets made of conventional partially pregelatinized corn starch disintegrated completely within 0.5 h, and sudden APAP release occurred. For both fully pregelatinized starches, sustained- release profiles were obtained in media without α-amylase. However, the drug-release rate from the fully pregelatinized starch matrix changed faster in media containing α-amylase. These results were the same phenomenon as described in previous work (11). On the other hand, matrix tablets made of HS were well controlled in the same way, with or without α-amylase. This situation can be explained by the high gel-forming ability of HS with high viscosity to prevent the dissolution and by the high resistance to α-amylase based on its degree of pregelatinization. HS has the same viscosity as HPMC and the moderate degree of pregelatinization between conventional partially pregelatinized starches and fully gelatinized starches (see Table I) contributes to its good balance of resistance to α-amylase and the gel-forming ability.

Based on this prescreening test, the following evaluations were done with HS and HPMC as matrix excipients: a dissolution study under high ionic-strength conditions, a dissolution study under high mechanical-force conditions, a zero-order release, and a storage stability of dissolution profiles and of tablet color.

Dissolution study under high ionic-strength conditions. The influence of ionic strength of dissolution media on APAP release rate was investigated. HS or HPMC matrix tablets containing APAP and MCC were prepared (HS or HPMC/APAP/MCC = 60%/ 10%/30%) and tested for dissolution using two media of different ionic strength: JP-2 buffer (ionic strength 0.20 M) and McIlvaine buffer (ionic strength 0.39 M).

Figure 3
Figure 3 shows the release profiles of APAP from HS and HPMC matrix tables. The release profiles of APAP from HS matrix tablets hardly changed between the JP-2 buffer and the McIlvaine buffer, but the profiles of HPMC were largely influenced by ionic strength. The HPMC matrix tablet couldn't maintain its matrix structure at high ionic-strength conditions, and burst release of APAP occurred. These results were caused by the difference in swelling ability in high-ionic-strength conditions. In the case of HPMC, as the ionic strength increases, the degree of swelling attributable to hydration decreases because the amount of water available to hydrate HPMC was reduced when more water is required to keep the ions in solution (5). In contrast, HS has a lot of hydroxyl groups on its backbone, so HS could hydrate in high ionic-strength conditions without competing with electrolytes.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here